³¤¸ý´óѧ»ùÒòתֳÊóºËÐÄʵÑéÊÒʹÓÃÒªµã
Chang
Gung University Transgenic Mouse Core Laboratory (TMCL) Guideline
|
ʵÑéÊÒÖ÷³ÖÈË£ºÅ·ÑôÆ·Ö÷ÈÎ Á¬ÂçÈË£ººúÖÇΰ 3171, 5008 |
||||||||||||||||||
|
¡¡
·þÎñÏîÄ¿£º A.ÔºËÏÔ΢עÉ䣨Pronuclei
microinjection£© B.ÅßÌ¥¸Éϸ°ûÖ®»ùÒò±êµÄ£¨ES
cell gene targeting£© C.ǶºÏÊóÉú²ú£¨Chimera
production£© D. ÅßÌ¥Àä¶³£¨Embryo cryopreservation£© E.ÚÑѯÒÔÏÂÊÂÏ 1. ÔØÌåÖ®¹¹Öþ£¨Gene
vector construction£© 2. תֳ»ùÒòÔØÌå¹¹Öþ¼°ÖƱ¸£¨Preparation
of constructs£© 3. »ùÒòתֳСÊó¼°»ùÒò±êµÄСÊóÖ®ËÇÓý¼°·±Ö³£¨Maintenance
of transgenic/ gene-targeted mouse lines£© 4.
»ùÒòתֳСÊó¼°»ùÒò±êµÄES
cell ¼ø±ð£¨Identification of
transgenic founder mice and correctly targeted ES clones£© ²»ÌṩÒÔÏ·þÎñÏîÄ¿ A.ÔØÌ弰תֳ»ùÒòÖ®Ìṩ¼°ÆäÖÆ±¸ B.»ùÒòתֳСÊóÖ®¼ø±ð C.»ùÒò±êµÄES
cellÖ®¼ø±ð D.»ùÒòתֳСÊó¼°»ùÒò±êµÄСÊóƷϵ֮´úÑø¼°·±Ö³ E.¸ö°¸½áÊøºó֮СÊóÅßÌ¥±£´æ ʹÓùæÔò A. »ùÒòתֳÊóºËÐÄʵÑéÊÒ£¨Transgenic
Mouse Core Laboratory£©ÒÔϼò³ÆTMCL£¬½«´Ó10/1/2002Æð½ÓÊܳ¤¸ýϵͳ֮ίÍУ¬Éú²ú»ùÒòתֳ¼°»ùÒò±êµÄСÊó¼°ÌṩÆäËüÏà¹Ø·þÎñ¡£ B. TMCLÖ®Êշѽ«Óɳ¤¸ý»ùÒòתֳÊóʹÓÃίԱ»á£¨Chang Gung Transgenic Mouse Use Committee£©ÌÖÂÛ¾ö¶¨£¬²¢ËæÊ±ÊÓÐèÒªÓÉίԱ»á¸ü¸ÄÖ®¡£ C. ίÍиö°¸ÒÀÊÕ¼þÈÕÆÚÏȺó˳Ðò¼°ÊýÁ¿Îª¸ö°¸½øÐÐÏȺóÖ®ÒÀ¾Ý£»Í¬Ò»ÉêÇëÈËÌá³öÒ»¸öÒÔÉÏÖ®¸ö°¸ÉêÇ룬ÈôÖ®ºóÓÐÆäËüÉêÇë¸ö°¸ÔòÒÔ´©²å·½Ê½½øÐС£ÊÕµ½ÉêÇë±íºóTMCLÈËÔ±»áÓëÉêÇëÈË×ö½øÒ»²½µÄÈ·ÈÏ¡£ÈôÓÐÆäËüÀýÍâÊÂÏÐèµ÷¶¯½øÐÐ֮˳Ðòʱ£¬ÔòÓÉίԱ»áе÷ºó¾ö¶¨¡£ D. תֳ»ùÒòÖ®À´Ô´¡¢±³¾°¡¢×ªÖ³»ùÒòÖ®¹¹ÖþͼÆ×£»ÒÔ¼°Óûתֳ»ùÒò֮СÊóƷϵµÈ¾ùÓ¦ÏêϸÌîдÓÚÉêÇë±íÉÏ£¬ÒÔÀûTMCLÈËÔ±ÓëÉêÇëÕß¼äÖ®¹µÍ¨¡£ E. ΪÔö½øTMCLÖ®Ö´ÐÐЧÂÊ£¬ÉêÇëÈËÓ¦Ïê¶ÁTMCLÖ®ÉêÇëÐëÖª£¬×ªÖ³»ùÒòÖ®ÖÆ±¸±ØÐë·ûºÏTMCLÖ®¹æ¶¨¡£Èôתֳ»ùÒòÖ®ÖÊÓëÁ¿²»·ûÒªÇ󣬽«ÓèÍ˼þ£¬¸ö°¸½øÐÐ֮ʱ³ÌÒཫÒò´ËÑÓ³Ù¡£ÈôÂŴβ»·ûÔòÈ¡ÏûίÍС£ F. TMCLֻʹÓý¡¿µ×´¿öÁ¼ºÃ¼°²»´øÓÐÌØ¶¨²¡Ô¾ú£¨SPF£©Ö®¶¯ÎÇÒËÇÓýÓÚ³¤¸ýʵÑ鶯ÎïÖÐÐÄÎÞÌØ¶¨²¡ÔÇøÄÚ¡£TMCL²»¸ºÔð¸ö°¸½áÊøºóÖ®¶¯Î。¿µ×´¿ö¡£ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ |
||||||||||||||||||
| ¡¡ | ||||||||||||||||||
|
ÔºËÏÔ΢עÉ䣨Pronuclei microinjection£© A.
ÊÂǰ׼±¸£ºÔÚÉêÇë»ùÒòתֳʵÑéǰ£¬±ØÐëÏÈÁ˽âÒÔÏÂÊÂÏî¡£ 1.ÒÑÍê³Éתֳ»ùÒòÖ®¹¹Öþ¡£ 2.ÒÑÈ·Á¢ÓÐЧɸѡתֳ»ùÒòÖ®·½·¨¡££¨ÈçPCR, Southern blot£© 3.ÓÐ×ã¹»µÄ¶¯Îï·¿¿Õ¼ä¿É¹©»ùÒòתֳСÊó·±Ö³¡£ 4.Á˽â»ùÒò×ªÖ³Ö®ÌØÐÔ£¬ÀýÈçÓÐЩ»ùÒòÊÜÏÞÓÚÆä×ÔÈ»ÌØÐÔ£¬ÎÞ·¨»ñµÃ»ùÒòתֳСÊó¡£ B.
СÊóƷϵ£ºTMCLÌṩ´¿Æ·ÏµFVB/N¼°´¿Æ·ÏµC57/B6СÊóΪÖ÷Òª¶ÔÏ󡣯äËüƷϵÔòÔݲ»Ìṩ¡£ C.
Òѹ¹ÖþÍê³ÉÖ®ÖÊÌ屨Ðë¿ÉÒÔÀûÓó£ÓõÄÏÞÖÆ D.
Ϊʹ»ùÒòתֳ֮ЧÂÊÌá¸ß£¬ÒÔϼ¸µãÇë×ñÊØ£º 1.
ÖÆ±¸Íê³É֮תֳ»ùÒòÖÊÌå±£´æ£¬²»¿É³¬¹ýÁ½ÖÜÒÔÉÏ¡£ 2.
¹¹ÖþÍê³ÉÖ®ÖÊÌåÇëÎðÏÈÐÐÒÔÏÞÖÆ 3.
´¦ÀíÍê³ÉÖ®ÖÊÌ屨ÐëÔÚ10¦ÌgÒÔÉÏ£¬Ìå»ý²»³¬¹ý100¦Ìl¡£Ëͽ»DNAʱ±ØÐ븽ÉϵçӾͼ£¬Çå³þ±êʾÓûתֳ»ùÒò֮Ƭ¶Î¡£ 4.
Ëͽ»DNAʱ±ØÐëÌîдʵ¼Ê֮Ũ¶È£¬²¢Ìṩ¿ÉÖ¤Ã÷Ö®×ÊÁÏ¡££¨ÈçO.D. ¼°¿É¶¨DNAŨ¶ÈÖ®µçӾͼ£© 5.
ÒÔÏÞÖÆ E.
ÿһ¸ö°¸½«ÖÁÉÙÌṩÎåÖ»´øÓÐתֳ»ùÒò֮СÊó£¬Èôͬһתֳ»ùÒòÒªÇó¸ü¶àÖ®»ùÒòתֳСÊóÓ¦ÊÓΪÁíÒ»¸öиö°¸¡£ÔÚTMCLÕý³£Ö®²Ù×÷³ÌÐòÏ£¬ÈôÒò²»¿É¿¹Á¦Ö®ÒòËØ¶øÎÞ»ùÒòתֳСÊó»òÊýÁ¿²»×㣬TMCL½«ÖØ×öÒ»´Î£¬¶ûºó½áÊø´ËÒ»¸ö°¸¡£ F.
½øÐÐ×¢ÉäºóÎå¸öÐÇÆÚ£¬TMCL½«Í¨ÖªÉêÇëÕßÈ¡»ØÐ¡Êóβ°Í¡£ÉêÇëÈ˱ØÐëÔÚÒ»¸öÐÇÆÚÄڻظ²²¢¸½ÉÏɸѡ½á¹û£¬Áì»ØÐ¡Êó¡£
G.
TMCL²»¸ºÔð»ùÒòתֳСÊóºóÐøÖ®´úÑø¼°·±Ö³¡£ H.
ËùÓÐÉêÇëʱËùÐèÌîÖ®±í¸ñ£¬¾ùÓ¦ÏêϸÌîд¡£ÈôÓÐÌîд²»ÇåÖ®´¦£¬Ó¦Óè²¹ÉϺó²ÅÍê³ÉÉêÇë¡£ÔÚ¸ö°¸½øÐÐÖÐÐèÌîд֮±í¸ñ£¬ÒàÐèÒ»Ò»ÏêϸÌîд¡£¹²ÓÐÒÔϱí¸ñÐèÌîд£º N0.1 Pronuclei
microinjection order form£ÉêÇëʱ N0.2
Prescreen confirmation form£ÉêÇëʱ N0.3
DNA material condition form£Ëͽ»DNAʱ N0.4
Tail sample release form£È¡»ØÎ²°Íʱ N0.5
Animal release form£Áì»Ø¶¯Îïʱ I.
Êշѱê×¼ 1.
2.
¸ö°¸¿ªÊ¼½øÐÐʱ¼´ÐÐÊÕ·Ñ¡£ 3. ίԱ»áµÃÊÓʵ¼ÊÇé¿öµ÷ÕûÊÕ·Ñ¡£ ¡¡ ¡¡ ¡¡ ¡¡ |
||||||||||||||||||
| ¡¡ | ||||||||||||||||||
|
ÅßÌ¥¸Éϸ°û»ùÒò±êµÄ£¨ES cell gene targeting£©
A. ÊÂǰ׼±¸£ºÔÚÉêÇë»ùÒòתֳʵÑéǰ£¬±ØÐëÏÈÁ˽âÒÔÏÂÊÂÏî¡£
1.
ÉêÇëǰÒÑÍê³É¹¹Öþתֳ»ùÒò¡£
2.
ÒÑÈ·Á¢»ùÒòÐͼø±ð·½·¨£¬°üÀ¨Long Arm¶Ë¼°Short
Arm¶ËµÄ¼ø±ð¡£
3.
Á˽â»ùÒò±êµÄʵÑéÖ®»ù±¾ÐÔÖÊ¡£ÀýÈçÓÐijЩ»ùÒòÊÜÆä×ÔÈ»ÏÞÖÆ»á½«½µµÍ´ËһʵÑéÖ®³É¹¦»úÂÊ¡£ B.
TMCLʹÓÃ129/SvJ or R1 Ʒϵ֮ES
cell¡£Òò´Ë¹¹Öþ»ùÒòʱ±ØÐëʹÓÃͬԴ»ùÒòÀ´½øÐÐʵÑé¡£ C.
Ϊά³ÖES
cellÖ®ÖÊÁ¿£¬TMCL½«Ê¹ÓÃÒÔÏÂÖ®¹æÔò²Ù×÷ 1.ÿһ´ÎתȾ£¨Transfection£©TMCLʹÓÃÖÁÉÙ6¡Á106 ES cell¡£ 2.Óû½øÐÐʵÑéÖ®DNA±ØÐëÓÐ100¦ÌgÒÔÉÏ£¬Ìå»ýСÓÚ400¦Ìl£¬ÇÒÔÚ×î½üÁ½ÖÜÄÚÖÆ±¸¡£ÒÔµ¥Ò»ÏÞÖÆ 3.»ùÒò±êµÄʵÑé»áÒòÓû´¦ÀíÖ®»ùÒò¡¢¹¹Öþ»ùÒòÖ®Éè¼Æ¡¢Ñ¡Ö³»ùÒòµÄÑ¡ÔñµÈµÈÒòËØÓ°Ï졣ʹµÃµ½ÕýÈ·Ö®ES cell»úÂÊÓкܴóµÄ±ä»¯£¨´Ó30-200±¶£©£¬Ò»°ãÀ´Ëµµ¥Ò»É¸Ñ¡Ò©Îï¿ÉÒÔ»ñµÃ200-300¸öÒÔÉϵÄϸ°ûÖê¡£Òò´ËTMCLÔÚÿһ´ÎʵÑéÖлáʹÓÃһС²¿·Öϸ°ûÓÃÓÚ¶ÔÕÕ×飨ֻ½øÐе¥Ò»É¸Ñ¡£©¡£ D.
ÔÚÒÔÏÂÇé¿öÏÂTMCL½«ÔÙ½øÐÐÃâ·ÑÖ®µÚ¶þ´ÎʵÑé¡£ 1.ÈôµÚÒ»´ÎʵÑéÎ޳ɹ¦±êµÄ֮ϸ°ûÖê¡£ 2.µÚÒ»´ÎʵÑéËù»ñµÃ֮ϸ°ûÖêÔÚ100¸öÒÔÏ£¬ÇÒûÓÐÁ½¸öÒÔÉϳɹ¦±êµÄ֮ϸ°ûÖê¡£TMCL½«Ê¹ÓÃÁ½±¶Ö®Ï¸°ûÊý£¨12¡Á106£©À´½øÐеڶþ´ÎʵÑé¡£ ³ý´ËÖ®Í⣬ÈôÉêÇëÕßÒªµÃµ½¸ü¶àµÄϸ°ûÖ꣬½«ÊÓΪÁíÒ»¸öиö°¸¡£ E.
ÕýÈ·µÄɸѡ½á¹û±ØÐëÔÚÊÕµ½ES cell genome DNAºóÒ»¸öÔ»ظ²¡£ H.
ËùÓÐÉêÇëʱËùÐèÌîÖ®±í¸ñ£¬¾ùÓ¦ÏêϸÌîд¡£ÈôÓÐÌîд²»ÇåÖ®´¦£¬Ó¦Óè²¹ÉϺó²ÅÍê³ÉÉêÇë¡£ÔÚ¸ö°¸½øÐÐÖÐÐèÌîд֮±í¸ñ£¬ÒàÐèÒ»Ò»ÏêϸÌîд¡£¹²ÓÐÒÔϱí¸ñÐèÌîд£º No.6 Gene
Targeting order form£ÉêÇëʱ No.2 Prescreen confirmation form£ÉêÇëʱ No.3
DNA material condition form£Ëͽ»DNAʱ No.7
ES cell genome DNA/ES cell release form£È¡»ØES cell »òES
cell genome DNA(gDNA)ʱ No.8
Screening result form£»Ø¸²½á¹ûʱ G.ÊÕ·Ñ£º 1.
2.¸ö°¸¿ªÊ¼½øÐÐʱ¼´ÐÐÊÕ·Ñ¡£ 3.ίԱ»áµÃÊÓʵ¼ÊÇé¿öµ÷ÕûÊÕ·Ñ¡£ ¡¡ ¡¡ |
||||||||||||||||||
| ¡¡ | ||||||||||||||||||
|
ǶºÏÊóÉú²ú£¨Chimera production£© A. ÊÂǰ׼±¸£ºÔÚÉêÇë»ùÒòתֳʵÑéǰ£¬±ØÐëÏÈÁ˽âÒÔÏÂÊÂÏî¡£ 1.
ÉêÇëǰÒѼø±ð³É¹¦±êµÄÖ®ES cellÖê¡£ 2.
ÒÑÕÒ³ö»ùÒòÐͼø±ð·½·¨¡£ 3.
ÓÐ×ã¹»µÄ¶¯Îï·¿¿Õ¼ä¿É¹©Ç¶ºÏÊóÖ®ÅäÖÖ¡£ 4.
Á˽ⲻÊÇÿһֻǶºÏÊ󶼿ÉÒÔ½«±êµÄ»ùÒòÒÅ´«¸øºó´ú¡£ 5.
ÉêÇëÕßÓÐÒåÎñ¸æÖªTMCLÆäǶºÏÊóÊÇ·ñ½«±êµÄ»ùÒòÒÅ´«ÖÁºó´ú¡£ B.
TMCLʹÓÃÄÒÅßÏÔ΢עÉ䣨Blastocyst microinjection£©À´Éú²úǶºÏÊó£¬TMCLÖ»½ÓÊÜÓÉTMCLËùÉú³ÉÖ®ES cellÀ´½øÐÐÏÔ΢עÉä¡£ÈôÉêÇëÕßÒѽ«ES
cellÁì»ØÒ಻½ÓÊÜ¡£ C.
TMCLʹÓÃC57BL/6Ö®ÄÒÅß½øÐÐʵÑé¡£ D.
TMCLÒÔÍâ±í֮ëƤÑÕÉ«×÷ΪǶºÏ³Ì¶È£¨Chimerism£©Ö®ÒÀ¾Ý¡£TMCL½ÓÊܵÄÿһ¸ö°¸½«ÖÁÉÙ¸øÉêÇëÕßÁùÖ»70 E.
ÈôÔÚµÚÒ»´Î×¢Éäºó·¢ÏÖǶºÏ³Ì¶È²»¸ß£¬TMCL½«Í¨ÖªÉêÇëÕß×öÒÔÏÂÁ½ÕßÖ®Ò»´¦Àí¡£ 1.TMCL½«½øÐиü¶àÖ®ÏÔ΢עÉäÒÔ´ïµ½ÁùÖ»70 2.½øÐÐÁíÍâÒ»¸öϸ°ûÖêµÄ×¢Éä¡££¨²»ÓèÊÕ·Ñ£© F.
TMCL²»¸ºÔðǶºÏÊóºóÐøÖ®ÅäÖÖ£¬ËùÓÐǶºÏÊó¾ùÐèÔÚÀëÈéºóÁì»Ø¡£ G.
ËùÓÐÉêÇëʱËùÐèÌîÖ®±í¸ñ£¬¾ùÓ¦ÏêϸÌîд¡£ÈôÓÐÌîд²»ÇåÖ®´¦£¬Ó¦Óè²¹ÉϺó²ÅÍê³ÉÉêÇë¡£ÔÚ¸ö°¸½øÐÐÖÐÐèÌîд֮±í¸ñ£¬ÒàÐèÒ»Ò»ÏêϸÌîд¡£¹²ÓÐÒÔϱí¸ñÐèÌîд£º No.9 Blastocyst microinjection order form£ÉêÇëʱ No.5 Animal release
form£Áì»Ø¶¯Îïʱ H.
ÊÕ·Ñ£º 1.ÿһ¸ö¸ö°¸°üº¬Á½¸öϸ°ûÖê×¢Éä
2.¸ö°¸¿ªÊ¼½øÐÐʱ¼´ÐÐÊÕ·Ñ 3.ίԱ»áµÃÊÓʵ¼ÊÇé¿öµ÷ÕûÊÕ·Ñ¡£ ¡¡ ¡¡ ¡¡ ¡¡ |
||||||||||||||||||
| ¡¡ | ||||||||||||||||||
|
ÅßÌ¥Àä¶³£¨Cryopreservation£© 1. ÉêÇëÐëÖª£º £¨1£© ±ØÐëÒÑÓÐʮֻÒÔÉϿɹ©ÅäÖֵĹ«Êó£¨ÁùÖÜÒÔÉÏ£©¡£ £¨2£© СÊó×åȺ±ØÐëÎÞ²¡Ô´¾úµÄÎÛȾ¡£ 2. ±¾ÖÐÐÄʹÓ󬼶ÅÅÂÑÀ´»ñµÃ´óÁ¿µÄÅßÌ¥ÒÔ¹©Àä¶³£¬ÉêÇëÕßӦ׼±¸ºÃÊʵ±ÖÜÁäµÄСÊóÒÔ¹©Ê¹Óᣠ3. ±¾ÖÐÐÄÒ»´ÎÉêÇ |